top of page

Lab awarded North Carolina Biotechnology Grant to screen SARS-CoV2+ plasma

The Polacheck Lab was awarded a 1-yr flash grant to determine whether microfluidic models of human microvasculature can predict cardiovascular risk for patients infected with the SARS-CoV2 virus. As a research tool, the lab will use the technology to understand how interactions between the virus and vascular endothelial cells contribute to disrupted endothelial integrity and downstream consequences.

Recent Posts

See All

コメント


bottom of page